Obesity and Hepatosteatosis in Mice with Enhanced Oxidative DNA Damage Processing in Mitochondria

Haihong Zhang, Chun-Yang Fan(Central Arkansas Veterans Healthcare System), Horace J. Spencer(University of Arkansas for Medical Sciences), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Philip A. Kern(University of Kentucky), Amanda J. Watson(University of Manchester), Geoffrey P. Margison(University of Manchester), Sankar Mitra(Houston Methodist), Bartosz Szczęsny(The University of Texas Medical Branch at Galveston), Cheng‐Hui Xie(University of Arkansas for Medical Sciences), Ming W. Chou(National Center for Toxicological Research), Chunlai Zuo(University of Arkansas for Medical Sciences), Masahiro Higuchi(University of Arkansas for Medical Sciences), Gouri Ranganathan(University of Arkansas for Medical Sciences)
American Journal Of Pathology
March 31, 2011
10.1016/j.ajpath.2010.12.038
Cited by 25

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells
|Cell Research|2008|655
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362